Title: INCITE Study. Intracranial haemorrhage in thrombocytopenic haematology patients. A case-control study.
Chief investigator: Dr Lise Estcourt
To advance the quality of care for haematology patients when they are receiving intensive chemotherapy, it is important to gain an in-depth understanding of the risk factors for life-threatening haemorrhage.
The aim of this study is to gain a greater understanding of the risk factors for intracranial haemorrhage (ICH) in haematology patients.
This case-control study concentrates on ICH because it is the most serious type of bleed caused by very low platelet counts.